Stock Scorecard

Stock Summary for Reviva Pharmaceuticals Holdings Inc (RVPH) - $0.29 as of 2/2/2026 9:07:25 AM EST

Total Score

11 out of 30

Safety Score

14 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RVPH

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RVPH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RVPH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RVPH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RVPH (14 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Financial Details for RVPH

Company Overview
Ticker RVPH
Company Name Reviva Pharmaceuticals Holdings Inc
Country N/A
Description N/A
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 9/30/2025
Next Earnings Date 3/23/2026

Stock Price History
Last Day Price 0.29
Price 4 Years Ago 4.25
Last Day Price Updated 2/2/2026 9:07:25 AM EST
Last Day Volume 2,148,456
Average Daily Volume 6,629,754
52-Week High 2.15
52-Week Low 0.25
Last Price to 52 Week Low 16.00%

Valuation Measures
Trailing PE N/A
Industry PE 26.68
Sector PE 188.49
5-Year Average PE -2.73
Free Cash Flow Ratio 2.64
Industry Free Cash Flow Ratio 12.86
Sector Free Cash Flow Ratio 30.14
Current Ratio Most Recent Quarter 1.39
Total Cash Per Share 0.11
Book Value Per Share Most Recent Quarter 0.05
Price to Book Ratio 7.55
Industry Price to Book Ratio 64.54
Sector Price to Book Ratio 57.14
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 30.05
Sector Price to Sales Ratio Twelve Trailing Months 20.56
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 116,850,000
Market Capitalization 33,886,500
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 23.79%
Reported EPS 12 Trailing Months -0.44
Reported EPS Past Year -0.33
Reported EPS Prior Year -1.66
Net Income Twelve Trailing Months -22,756,700
Net Income Past Year -29,918,802
Net Income Prior Year -39,260,837
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 13,183,259
Total Cash Past Year 13,476,331
Total Cash Prior Year 23,367,456
Net Cash Position Most Recent Quarter 13,183,259
Net Cash Position Past Year 13,476,331
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 812,572
Total Stockholder Equity Prior Year 5,718,716
Total Stockholder Equity Most Recent Quarter 4,549,735

Free Cash Flow
Free Cash Flow Twelve Trailing Months -27,896,936
Free Cash Flow Per Share Twelve Trailing Months -0.24
Free Cash Flow Past Year -33,543,920
Free Cash Flow Prior Year -28,324,356

Options
Put/Call Ratio 0.46
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.04
MACD Signal -0.04
20-Day Bollinger Lower Band 0.19
20-Day Bollinger Middle Band 0.48
20-Day Bollinger Upper Band 0.76
Beta 0.08
RSI 35.29
50-Day SMA 0.67
150-Day SMA 0.00
200-Day SMA 0.00

System
Modified 1/31/2026 7:11:02 AM EST